Gat,
This is in a very good explanation.. About an Indian drug company and only distribution by the Clinton group..
For a full understanding, read the article by using the link..
The allegations are false. Again and again, they have been found false.. Started by a Republican who is simply lying and picked up and pushed by the daily caller...
http://www.politifact.com/global-news/statements/2016/sep/23/daily-caller/conservative-website-wrongly-ties-clinton-foundati/Our ruling
The Daily Caller said that the Clinton Foundation and the Clinton Health Access Initiative distributed "watered-down HIV/AIDS drugs to patients in sub-Saharan Africa."
At the most literal level, the statement is a misreading of a report from a conservative Republican who said the foundation "likely facilitated" the distribution of watered-down HIV/AIDS drugs.
Neither version of the claim -- centering around the drugmaker Ranbaxy -- is proven. In fact, a host of regulatory agencies have found the drugs in question to be safe.
The U.S. Food and Drug Administration said there was no evidence the drugs themselves were substandard. The World Health Organization, South Africa’s Medicines Control Council and the British Medicines and Healthcare Products Regulatory Agency tested the Ranbaxy drugs and found them to be safe. Such testing dates back to at least 2005.
We rate this statement False.
Update and correction (Sept. 29, 2016): After this item posted, we heard from Mark Tapscott, executive editor of the Daily Caller News Foundation, a 501(c)3 organization that says it provides investigative reporting for the public benefit. The group does not publicly list its donors. Tapscott listed what he called nine factual errors in our story. We reviewed his claims and found most of them without merit, as they failed to distinguish between Ranbaxy’s HIV/AIDS drugs and its other products.
Tapscott, however, correctly noted that in 2004 WHO decertified three of Ranbaxy’s HIV/AIDS drugs. Ranbaxy’s HIV/AIDS drugs were recertified the following year. The story now reflects that information, as well as the correct year in which the Justice Department filed charges against Ranbaxy.
Our rating remains unchanged.